Other languages Terns Pharmaceuticals, Inc.

Equities

TERN

US8808811074

Real-time Estimate Cboe BZX Other stock markets 02:18:50 2024-04-26 pm EDT			5-day change	1st Jan Change
4.815 ^USD	+3.77%		+5.92%	-25.58%

Apr. 10	Terns Pharmaceuticals, Inc. Appoints Melita Sun Jung as Chief Business Officer	CI
Mar. 27	UBS Trims Terns Pharmaceuticals Price Target to $18 From $19, Maintains Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Terns Pharmaceuticals, Inc. Appoints Melita Sun Jung as Chief Business Officer	Apr. 10
Terns Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14
Terns Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 14
Terns Pharmaceuticals Gets Orphan Drug Label for Chronic Myeloid Leukemia Treatment Candidate	Mar. 11
Terns Pharmaceuticals, Inc. Appoints Amy Burroughs as Chief Executive Officer	Feb. 07
Terns Pharmaceuticals, Inc. Appoints Amy Burroughs as Member of Board of Directors	Feb. 07
Terns Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Terns Pharmaceuticals, Inc. Announces First Participant Dosed in Phase 1 Clinical Trial of TERN-601 Oral GLP-1 Receptor Agonist for Treatment of Obesity	Nov. 02
Terns Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08
Terns Pharmaceuticals, Inc. Achieves Primary Endpoint and All Secondary Endpoints in Phase 2a DUET Trial of THR-ß Agonist TERN-501 in NASH	23-08-08
Terns Pharmaceuticals, Inc. Announces Leadership Transition	23-08-03
Terns Pharmaceuticals Announces Leadership Transition	23-08-03
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday	23-06-27
Terns Pharmaceuticals Says New Preclinical Data of TERN-601 Shows Improved Glucose Tolerance in Mouse Model	23-06-26
Terns Pharmaceuticals, Inc. Highlights New Preclinical Data for TERN-601 Program in Obesity at the ADAâ€™s 83rd Annual Scientific Session	23-06-26
Terns Pharmaceuticals Offers 35% Upside With $1 Billion-Plus Products in Pipeline, Upcoming NASH Data, Mizuho Says	23-06-22
Terns Pharmaceuticals Q1 Net Loss per Share Narrows	23-05-15
Terns Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Terns Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-27
Terns Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Terns Pharmaceuticals, Inc.

Equities

TERN

US8808811074

Other languages

Filters